Bruce Linton thinks investors will warm back to the cannabis sector – they just need a few more months handling some of these new infused products to reignite their interest in the space.
Linton, the former Canopy Growth CEO and current executive chairman of Vireo Health, told BNN Bloomberg that retail investors will likely return to some key cannabis companies once they can see the infused edibles, drinks and extracts that are now legally allowed for sale in Canada.
“The level of enthusiasm and anticipation for that, I think, is not on par with what is being presented. So I think in January and February, a lot of retail [investors] are going to see these products and want that stock that makes that product,” Linton said.
He added that he’s more interested in the opportunities emerging in the U.S. and European cannabis markets and is hopeful that in the Canadian market, some well-established firms can emerge as profitable businesses that can leverage their domestic operations and expand internationally.
Full story and interview from BNN Bloomberg
here.